Skip to main content
. 2006 Dec 14;10(6):R174. doi: 10.1186/cc5126

Table 1.

Demographic features of study of patients

All patients (n = 331) PiCCO (n = 192) PAC (n = 150) p value
At ICU admission
Gender (male) 58.9% 57.3% 60.0% 0.66
Age in years 67 (54, 75) 64 (47, 74) 68 (57, 76) 0.0037
NYHA: III, IV 11.5% 10.9% 12.0% 0.86
IHD 31.1% 32.3% 28.7% 0.48
COPD 16.0% 14.1% 18.7% 0.30
Diabetes 22.1% 25.0% 19.3% 0.24
Previous renal function
 Normal 58.6% 59.4% 58.7% 0.91
 Impaired 22.4% 22.4% 22.0% >0.99
 ESRF 3.9% 4.7% 2.7% 0.40
 Unknown 15.1% 13.5% 16.7% 0.45
SAPS II 49 (37, 61) 49 (37, 61) 47 (37, 61) 0.91
At study inclusion
Vasopressors 73.4% 75.0% 71.3% 0.46
Inotropic drugs 22.1% 13.0% 37.3% <0.0001
Heart rate (beats per minute) 98 (84, 115) 99 (85, 118) 97 (84, 111) 0.48
MAP (mm Hg) 75 (68, 85) 76 (70, 85) 73 (63, 84) 0.0086
Cardiac index (litres/minute per m2) 3.0 (2.3, 4.0) 3.2 (2.6, 4.5) 2.6 (2.1, 3.5) <0.0001
CVP (mm Hg) 12 (8, 15) 12 (9, 16) 11 (8, 14) 0.011
ITBI (ml/m2) - 967 (768, 1,140) -
ELWI (ml/kg) - 8.9 (6.6, 13.0) -
PAOP (mm Hg) - - 17 (12, 22)
Mechanical ventilation 81.6% 80.2% 84.0% 0.40
PEEP (cm H2O) 5 (5, 10) 6 (5, 10) 5 (5, 8) 0.21
PaO2/FiO2 ratio (Torr) 186 (125, 279) 191 (126, 279) 185 (125, 285) 0.87
RRT 21.4% 26.6% 16.7% 0.036
Urea (mmol/l) 12.1 (7.1, 19.0) 12.0 (7.1, 18.7) 12.2 (7.1, 19.1) 0.91
Creatinine (μmol/l) 142 (100, 231) 151 (100, 231) 137 (97, 230) 0.42

Values are presented as medians (with 25th and 75th percentiles) or as percentages. COPD, chronic obstructive pulmonary disease; CVP, central venous pressure; ELWI, extra-vascular lung water index; ESRF, end-stage renal failure; ICU, intensive care unit; IHD, ischaemic heart disease; ITBI, intra-thoracic blood volume index; MAP, mean arterial pressure; NYHA, New York Heart Association; PAC, pulmonary artery catheter; PAOP, pulmonary artery occlusion pressure; PaO2/FiO2, partial pressure of oxygen in arterial blood/fraction of inspired oxygen; PEEP, positive end-expiratory pressure; PiCCO, pulse contour cardiac output; RRT, renal replacement therapy; SAPS II, simplified acute physiology score.